Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study

BACKGROUND: The present single-center clinical trial was designed to evaluate the potential benefits of L-carnitine supplementation in patients with COVID-19 disease. METHODS AND PATIENTS: The study was conducted on 75 patients with mild-to-moderate COVID-19 hospitalized in Shahid Beheshti Hospital-...

Descripción completa

Detalles Bibliográficos
Autores principales: Talebi, Seyed Saman, Ghasemi, Mehran, Etminani-Esfahani, Maryam, Mohammadi, Younes, Haddadi, Rasool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Special Issue: Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395946/
https://www.ncbi.nlm.nih.gov/pubmed/35997951
http://dx.doi.org/10.1007/s43440-022-00402-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395946/
https://www.ncbi.nlm.nih.gov/pubmed/35997951
http://dx.doi.org/10.1007/s43440-022-00402-y

Ejemplares similares